“…Dyslipoproteinemia deregulation was observed in SLE, namely by low levels of HDL cholesterol and elevated levels of both VLDL cholesterol and triglycerides (TG) [67]. Lupus patients also show increased concentrations of oxidized LDL and an anomalous chylomicron metabolism, which is consistent with the higher levels of 4-HNE [52,68,69]. Levels of oxidized LDL detected by the monoclonal antibody E06 are significantly higher in SLE patients and are associated with cardiovascular disease that develop in SLE [74,75].…”